OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epstein–Barr virus associated lymphomas in people with HIV
Antonino Carbone, Chiara Costanza Volpi, Ambra V. Gualeni, et al.
Current Opinion in HIV and AIDS (2016) Vol. 12, Iss. 1, pp. 39-46
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus
Abhik Saha, Erle S. Robertson
Journal of Virology (2019) Vol. 93, Iss. 13
Open Access | Times Cited: 118

Recommendations for measuring HIV reservoir size in cure-directed clinical trials
Mohamed Abdel‐Mohsen, Douglas D. Richman, Robert F. Siliciano, et al.
Nature Medicine (2020) Vol. 26, Iss. 9, pp. 1339-1350
Open Access | Times Cited: 113

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells
Mohamed Abdel‐Mohsen, Leticia Kuri-Cervantes, Judith Grau-Expósito, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 437
Open Access | Times Cited: 100

HIV/AIDS Associated Lymphoma: Review
Ayenew Berhan, Biruk Bayleyegn, Zegeye Getaneh
Blood and Lymphatic Cancer Targets and Therapy (2022) Vol. Volume 12, pp. 31-45
Open Access | Times Cited: 46

Cancer and HIV: The Molecular Mechanisms of the Deadly Duo
Aadilah Omar, N M Marques, Nicole Crawford
Cancers (2024) Vol. 16, Iss. 3, pp. 546-546
Open Access | Times Cited: 11

New Look of EBV LMP1 Signaling Landscape
Ling Wang, Shunbin Ning
Cancers (2021) Vol. 13, Iss. 21, pp. 5451-5451
Open Access | Times Cited: 49

Virological Markers in Epstein–Barr Virus-Associated Diseases
Julien Lupo, Aurélie Truffot, Julien Andréani, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 656-656
Open Access | Times Cited: 21

Epstein Barr Virus-Associated Hodgkin Lymphoma
Antonino Carbone, Annunziata Gloghini
Cancers (2018) Vol. 10, Iss. 6, pp. 163-163
Open Access | Times Cited: 35

Comprehensive immunoinformatics and structural biology based design for novel peptide vaccines against Epstein-Barr virus
Anam Naz, Hassan Yousaf, Naila Zaman, et al.
Gene Reports (2025), pp. 102137-102137
Closed Access

Le diagnostic virologique des maladies associées au virus d’Epstein-Barr
Julien Lupo, Aurélie Truffot, Patrice Morand, et al.
Revue de biologie médicale. (2025) Vol. nº 383, Iss. 2, pp. 41-56
Closed Access

HIV Co-infection Augments EBV-Induced Tumorigenesis in vivo
Christopher B. Whitehurst, Monica Rizk, Adonay Teklezghi, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 13

New insights into pathogenesis point to HIV-1 Tat as a key vaccine target
Barbara Ensoli, Sonia Moretti, Alessândra Borsetti, et al.
Archives of Virology (2021) Vol. 166, Iss. 11, pp. 2955-2974
Open Access | Times Cited: 17

Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights
S. Balaji, Rohan Chakraborty, Sumit Aggarwal
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 284-305
Closed Access | Times Cited: 7

18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma
Ismaheel O. Lawal, Alfred O. Ankrah, Gbenga O. Popoola, et al.
Nuclear Medicine Communications (2018) Vol. 39, Iss. 11, pp. 1005-1012
Closed Access | Times Cited: 19

How Epstein Barr Virus Causes Lymphomas
Ya‐Fang Chiu, Khongpon Ponlachantra, Bill Sugden
Viruses (2024) Vol. 16, Iss. 11, pp. 1744-1744
Open Access | Times Cited: 2

Epstein–Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era
Julien Lupo, Raphaële Germi, Rémi Lancar, et al.
AIDS (2019) Vol. 33, Iss. 6, pp. 993-1000
Open Access | Times Cited: 14

Role of Natural Killer Cells in HIV-Associated Malignancies
Fábio E. Leal, Thomas A. Premeaux, Mohamed Abdel‐Mohsen, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 12

Prospective evaluation of blood Epstein–Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas
Julien Lupo, Raphaële Germi, Rémi Lancar, et al.
AIDS (2021) Vol. 35, Iss. 6, pp. 861-868
Open Access | Times Cited: 9

Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome
Andrés Chang, Danielle Schlafer, Christopher R. Flowers, et al.
Expert Opinion on Investigational Drugs (2017) Vol. 27, Iss. 1, pp. 55-70
Open Access | Times Cited: 7

Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma
Mariana Bastos‐Oreiro, Pascual Balsalobre, Pilar Miralles, et al.
Bone Marrow Transplantation (2020) Vol. 55, Iss. 9, pp. 1716-1725
Closed Access | Times Cited: 6

Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study
Laura E. Martínez, Shelly Lensing, Di Chang, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 16, pp. 4642-4651
Open Access | Times Cited: 6

Oropharyngeal Shedding of Gammaherpesvirus DNA by Cats, and Natural Infection of Salivary Epithelium
Elizabeth C. Rose, Tiffany Tse, Andrew W. Oates, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 566-566
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top